CCS 2022 Dyslipidemia Guidelines Pocket Guide

Zusammenfassung

DYSLIPIDEMIA DYSLIPIDEMIA UPDATE 2 0 2 1 DYSLIPIDEMIA About this Pocket Guide This pocket guide is a quick-reference tool that features diagnostic and treatment recommendations based on the 2021 CCS Dyslipidemia Guidelines (as well as, recommendations from the previous dyslipidemia guidelines that remain unchanged [2006, 2009, 2012, and 2016]). These recommendations are intended to provide a reasonable and practical approach to care for physicians, pharmacists, nurses and other healthca

Kerninformationen

Pearson, PharmD FCCS and George Thanassoulis, MD CCS Dyslipidemia Guidelines Primary Panel Todd J. Anderson MD, Arden R. Barry PharmD, Patrick Couture MD PhD, Natalie Dayan MD, Gordon A. Francis MD, Jacques Genest MD, Jean Grégoire MD, Steven A. Grover MD, Milan Gupta MD, Robert A. Hegele MD, Davi...

Who to Screen 3 5 *Men younger than 55 years of age and women younger than 65 years of age in first degree relatives. **Chronic Kidney Disease = eGFR ≤60 mL/min/1.73 m2 or ACR ≥3 mg/mmol for at least 3 months duration. ACR = albumin-to-creatinine ratio; AS = ankylosing spondylitis; BMI = body mass i...

Values and preferences - Patients with modifiable ASCVD risk factors should be counselled with respect to the potential merit of preventing atherosclerosis itself, the substrate for clinical ASCVD events in the long term, through comprehensive ASCVD risk factor management. As outlined elsewhere, R...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen